-

OrganaBio to exhibit at 2022 ASH Annual Meeting and Exposition

original OrganaBio to exhibit at 2022 ASH Annual Meeting and Exposition in New Orleans, LA. Visit booth 2143 to learn more about our unique, flexible model which combines proprietary and scalable tissue sourcing with advanced processing and characterization of perinatal and adult peripheral blood (including umbilical cord blood and leukopaks). (Graphic: Business Wire)

OrganaBio to exhibit at 2022 ASH Annual Meeting and Exposition in New Orleans, LA. Visit booth 2143 to learn more about our unique, flexible model which combines proprietary and scalable tissue sourcing with advanced processing and characterization of perinatal and adult peripheral blood (including umbilical cord blood and leukopaks). (Graphic: Business Wire)

NEW ORLEANS--(BUSINESS WIRE)--Attending ASH22 American Society of Hematology between December 10-12?

Our unique, flexible model combines proprietary and scalable tissue sourcing with advanced processing and characterization of perinatal and adult peripheral blood (including umbilical cord blood and leukopaks). OrganaBio can tailor our products and services to your evolving needs, such as rapidly manufacturing a variety of isolated cells such as CD34+ HSCs, T, B & NK Cells, and macrophages from tissues for pre-clinical research use as well as in the manufacturing of clinical-grade cell therapies. Visit us at booth 2143 or schedule a time to meet with our VP of Corporate Development, Dr. Priya Baraniak: https://meetings.hubspot.com/priya21/meet-with-dr-priya-baraniak

Contacts

Dr. Priya Baraniak
Vice President of Corporate Development
priya@organabio.com

Industry:

OrganaBio

Details
Headquarters: South Miami, FL
CEO: Justin Irizarry
Employees: 50
Organization: PRI
Release Versions
English
Hashtags
#ASH22
#celltherapy
#hematology
#immunotherapy

Contacts

Dr. Priya Baraniak
Vice President of Corporate Development
priya@organabio.com

Social Media Profiles
OrganaBio LinkedIn
More News From OrganaBio

OrganaBio Expands to the San Francisco Bay Area with New PBMC Processing Laboratory in Hayward, California

SAN FRANCISCO--(BUSINESS WIRE)--OrganaBio opens up a new PBMC processing lab in the Greater San Francisco area to support rapid isolation of PBMCs from clinical trial samples...

OrganaBio Approved as A Science Exchange and Scientist.com Partner

MIAMI--(BUSINESS WIRE)--OrganaBio products and services can now be accessed via the Science Exchange and Scientist.com platforms. Both online marketplaces allow buyers to find and request services directly through the platform and help streamline communication and buying processes through standardized proposal and contracting mechanisms. Drug developers can now leverage www.scienceexchange.com and www.scientist.com and search for OrganaBio’s services and products specifically (e.g. donor screen...

GaiaGift Triples Physician Network to Ethically Collect Increasing Volumes of Birth Tissues Needed for the Rapidly Burgeoning Development of Cell and Gene Therapies

MIAMI--(BUSINESS WIRE)--GaiaGift, LLC (a wholly owned subsidiary of OrganaBio, LLC) a leader in the field of birth tissue collection, announces the expansion of its esteemed physician network, offering more opportunities for donors to participate in its remarkable donation program supporting the development of novel cell and gene therapies. GaiaGift's mission is to empower families to make a positive impact on healthcare by ethically donating otherwise discarded birth tissue, contributing to gr...
Back to Newsroom